Jeff Eidel - 16 Feb 2024 Form 4 Insider Report for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

Role
Chief Commercial Officer
Signature
/s/ Michele Farmer, Attorney-in-fact
Issuer symbol
PACB
Transactions as of
16 Feb 2024
Net transactions value
-$92,337
Form type
4
Filing time
21 Feb 2024, 18:20:57 UTC
Previous filing
18 Aug 2023
Next filing
26 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PACB Common Stock Sale $92,337 -15,498 -3.5% $5.96 431,824 16 Feb 2024 Direct F1, F2, F3
holding PACB Common Stock 208 16 Feb 2024 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 This sale price represents the weighted average sale price of the shares sold ranging from $5.69 to $6.65 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3 Includes 2,656 shares purchased on September 1, 2023 under the Company's 2010 Employee Stock Purchase Plan.

Remarks:

Chief Commercial Officer